Lifeward Stock

Lifeward Equity

The The Equity of Lifeward (LFWD) as of Aug 4, 2026 is 18.85 M USD. In the previous year, The Equity was 46.51 M USD — a change of -59.47% (lower).

Equity

18.85 MUSD

YoY

-59.47%

Last updated:

In 2026, Lifeward's equity was 18.85 M USD, a -59.47% increase from the 46.51 M USD equity in the previous year.

Access this data via the Eulerpool API

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Lifeward's Equity

Lifeward's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Lifeward's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Lifeward's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Lifeward's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Lifeward’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Lifeward stock

The Equity of Lifeward is 18.85 M USD in 2026.

The Equity of Lifeward changed from 46.51 M USD to 18.85 M USD, representing a -59.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Lifeward since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Lifeward historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Lifeward

All Key Metrics — Lifeward